 |
PDBsum entry 1skz
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Serine protease inhibitor
|
PDB id
|
|
|
|
1skz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Embo J
16:5151-5161
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa.
|
|
R.Lapatto,
U.Krengel,
H.A.Schreuder,
A.Arkema,
B.de Boer,
K.H.Kalk,
W.G.Hol,
P.D.Grootenhuis,
J.W.Mulders,
R.Dijkema,
H.J.Theunissen,
B.W.Dijkstra.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The three-dimensional structure of antistasin, a potent inhibitor of blood
coagulation factor Xa, from the Mexican leech Haementeria officinalis was
determined at 1.9 A resolution by X-ray crystallography. The structure reveals a
novel protein fold composed of two homologous domains, each resembling the
structure of hirustasin, a related 55-residue protease inhibitor. However,
hirustasin has a different overall shape than the individual antistasin domains,
it contains four rather than two beta-strands, and does not inhibit factor Xa.
The two antistasin domains can be subdivided into two similarly sized subdomains
with different relative orientations. Consequently, the domain shapes are
different, the N-terminal domain being wedge-shaped and the C-terminal domain
flat. Docking studies suggest that differences in domain shape enable the
N-terminal, but not C-terminal, domain of antistasin to bind and inhibit factor
Xa, even though both have a very similar reactive site. Furthermore, a putative
exosite binding region could be defined in the N-terminal domain of antistasin,
comprising residues 15-17, which is likely to interact with a cluster of
positively charged residues on the factor Xa surface (Arg222/Lys223/Lys224).
This exosite binding region explains the specificity and inhibitory potency of
antistasin towards factor Xa. In the C-terminal domain of antistasin, these
exosite interactions are prevented due to the different overall shape of this
domain.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4 Stereo view showing the superposition of the N- and
C-terminal domains of antistasin, based on the C coordinates
of the second subdomains, respectively [using the program O
(Jones et al., 1991); figure produced with Molscript (Kraulis,
1991)]. The N-terminal domain (black) adopts a wedge shape,
while the C-terminal domain (grey) is relatively flat.
|
 |
Figure 5.
Figure 5 Schematic representation of the antistasin fold. The
orientation of antistasin is similar to the one chosen in Figure
3. Disulfide connectivities and the linker residues connecting
the two subdomains within each domain are indicated. The
scissile bond is marked by an arrow. -strands
involve amino acid residues 41 -43 and 49 -53 in the N-terminal
domain and residues 96 -98 and 104 -108 in the C-terminal
domain, respectively.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
Embo J
(1997,
16,
5151-5161)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Y.Koh,
and
R.M.Kini
(2008).
Anticoagulants from hematophagous animals.
|
| |
Expert Rev Hematol,
1,
135-139.
|
 |
|
|
|
|
 |
C.A.Kontogiorgis,
and
D.Hadjipavlou-Litina
(2004).
Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.
|
| |
Med Res Rev,
24,
687-747.
|
 |
|
|
|
|
 |
G.Izaguirre,
W.Zhang,
R.Swanson,
T.Bedsted,
and
S.T.Olson
(2003).
Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
|
| |
J Biol Chem,
278,
51433-51440.
|
 |
|
|
|
|
 |
C.Manithody,
L.Yang,
and
A.R.Rezaie
(2002).
Role of basic residues of the autolysis loop in the catalytic function of factor Xa.
|
| |
Biochemistry,
41,
6780-6788.
|
 |
|
|
|
|
 |
A.M.Krezel,
J.S.Ulmer,
G.Wagner,
and
R.A.Lazarus
(2000).
Recombinant decorsin: dynamics of the RGD recognition site.
|
| |
Protein Sci,
9,
1428-1438.
|
 |
|
|
|
|
 |
B.M.Duggan,
H.J.Dyson,
and
P.E.Wright
(1999).
Inherent flexibility in a potent inhibitor of blood coagulation, recombinant nematode anticoagulant protein c2.
|
| |
Eur J Biochem,
265,
539-548.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Czapinska,
and
J.Otlewski
(1999).
Structural and energetic determinants of the S1-site specificity in serine proteases.
|
| |
Eur J Biochem,
260,
571-595.
|
 |
|
|
|
|
 |
H.Raaijmakers,
O.Vix,
I.Törõ,
S.Golz,
B.Kemper,
and
D.Suck
(1999).
X-ray structure of T4 endonuclease VII: a DNA junction resolvase with a novel fold and unusual domain-swapped dimer architecture.
|
| |
EMBO J,
18,
1447-1458.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.Usón,
G.M.Sheldrick,
E.de La Fortelle,
G.Bricogne,
S.Di Marco,
J.P.Priestle,
M.G.Grütter,
and
P.R.Mittl
(1999).
The 1.2 A crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitors.
|
| |
Structure,
7,
55-63.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |